Transcriptomic and Proteomic Profile of Aspergillus fumigatus on Exposure to Artemisinin
Artemisinin, an antimalarial drug, and its derivatives are reported to have antifungal activity against some fungi. We report its antifungal activity against Aspergillus fumigatus (A. fumigatus), a pathogenic filamentous fungus responsible for allergic and invasive aspergillosis in humans, and its synergistic effect in combination with itraconazole (ITC), an available antifungal drug. In order to identify its molecular targets, we further analyzed transcript and proteomic profiles of the fungus on exposure to the artemisinin. In transcriptomic analysis, a total of 745 genes were observed to be modulated on exposure to artemisinin, and some of them were confirmed by real-time polymerase chain reaction analysis. Proteomic profiles of A. fumigatus treated with artemisinin showed modulation of 175 proteins (66 upregulated and 109 downregulated) as compared to the control. Peptide mass fingerprinting led to the identification of 85 proteins—29 upregulated and 56 downregulated, 65 of which were unique proteins. Consistent with earlier reports of molecular mechanisms of artemisinin and that of other antifungal drugs, we believe that oxidative phosphorylation pathway (64 kDa mitochondrial NADH dehydrogenase), cell wall-associated proteins and enzymes (conidial hydrophobin B protein, cell wall phiA protein, extracellular thaumatin domain protein, 1,3-beta-glucanosyltransferase Gel2) and genes involved in ergosterol biosynthesis (ERG6 and coproporphyrinogen III oxidase, HEM13) are potential targets of artemisinin for further investigations.
KeywordsAspergillus fumigatus Artemisinin Microarray Proteomics
We are grateful to Council of Scientific and Industrial Research and Department of Science and Technology, Government of India, for the financial support. We are grateful to Pathogen Functional Genomics Resource Center (PFGRC) at J. Craig Venter Institute (JCVI, Rockville, Maryland, USA) for providing A. fumigatus microarray slides. We are also thankful to The Centre for Genomic Application (TCGA) for providing the microarray facility. We acknowledge Dr. D. W. Denning, School of Medicine, University of Manchester, Manchester, UK, for providing the Af293 strain. Dr. Poonam Gautam was recipient of Research Associate Fellowship of Department of Science and Technology, Government of India, and Dr. Santosh Kumar Upadhyay was recipient of Senior Research Fellowship of Council of Scientific and Industrial Research, Government of India.
- 3.Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother. 2002;9:7–10.Google Scholar
- 7.Dhingra V, Pakki SR, Narasu ML. Antimicrobial activity of artemisinin and its precursors. Curr Sci. 2000;78(6):709–13.Google Scholar
- 28.Chumbalkar VC, Subhashini C, Dhople VM, Sundaram CS, Jagannadham MV, Kumar KN, Srinivas PN, Mythili R, Rao MK, Kulkarni MJ, Hegde S, Hegde AS, Samual C, Santosh V, Singh L, Sirdeshmukh R. Differential protein expression in human gliomas and molecular insights. Proteomics. 2005;5(4):1167–77.PubMedCrossRefGoogle Scholar
- 30.Agarwal AK, Rogers PD, Baerson SR, Jacob MR, Barker KS, Cleary JD, Walker LA, Nagle DG, Clark AM. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cereviseae. J Biol Chem. 2003;278(37):34998–5015.PubMedCrossRefGoogle Scholar
- 39.Mouyna I, Morelle W, Vai M, Monod M, Léchenne B, Fontaine T, Beauvais A, Sarfati J, Prévost MC, Henry C, Latgé JP. Deletion of GEL2 encoding for a beta(1–3) glucanosyltransferase affects morphogenesis and virulence in Aspergillus fumigatus. Mol Microbiol. 2005;56(6):1675–88.PubMedCrossRefGoogle Scholar
- 42.Barker KS, Crisp S, Wiederhold N, Lewis RE, Bareither B, Eckstein J, Barbuch R, Bard M, Rogers PD. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J Antimicrob Chemother. 2004;54(2):376–85.PubMedCrossRefGoogle Scholar
- 43.Alcazar-Fuoli L, Mellado E, Garcia-Effron G, Buitrago MJ, Lopez JF, Grimalt JO, Cuenca-Estrella JM, Rodriguez-Tudela JL. Aspergillus fumigatus C-5 sterol desaturases Erg3A and Erg3B: role in sterol biosynthesis and antifungal drug susceptibility. Antimicrob Agents Chemother. 2006;50(2):453–60.PubMedCrossRefGoogle Scholar
- 48.Slaven JW, Anderson MJ, Sanglard D, Dixon GK, Bille J, Roberts IS, Denning DW. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol. 2002;36:199–206.PubMedCrossRefGoogle Scholar